BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32814048)

  • 41. Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases.
    Williamson R; Scales T; Clark BR; Gibb G; Reynolds CH; Kellie S; Bird IN; Varndell IM; Sheppard PW; Everall I; Anderton BH
    J Neurosci; 2002 Jan; 22(1):10-20. PubMed ID: 11756483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NLRP3 inflammasome activation drives tau pathology.
    Ising C; Venegas C; Zhang S; Scheiblich H; Schmidt SV; Vieira-Saecker A; Schwartz S; Albasset S; McManus RM; Tejera D; Griep A; Santarelli F; Brosseron F; Opitz S; Stunden J; Merten M; Kayed R; Golenbock DT; Blum D; Latz E; Buée L; Heneka MT
    Nature; 2019 Nov; 575(7784):669-673. PubMed ID: 31748742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The microtubule-associated protein tau is also phosphorylated on tyrosine.
    Lebouvier T; Scales TM; Williamson R; Noble W; Duyckaerts C; Hanger DP; Reynolds CH; Anderton BH; Derkinderen P
    J Alzheimers Dis; 2009; 18(1):1-9. PubMed ID: 19542604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tau exhibits unique seeding properties in globular glial tauopathy.
    Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
    Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
    Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of tau pathology in tau transgenic models.
    Brion JP; Ando K; Heraud C; Leroy K
    Biochem Soc Trans; 2010 Aug; 38(4):996-1000. PubMed ID: 20658992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.
    Li L; Jiang Y; Hu W; Tung YC; Dai C; Chu D; Gong CX; Iqbal K; Liu F
    Mol Neurobiol; 2019 Sep; 56(9):6168-6183. PubMed ID: 30734228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
    J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.
    Bhaskar K; Hobbs GA; Yen SH; Lee G
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):462-77. PubMed ID: 20609109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frontotemporal dementia mutant Tau promotes aberrant Fyn nanoclustering in hippocampal dendritic spines.
    Padmanabhan P; Martínez-Mármol R; Xia D; Götz J; Meunier FA
    Elife; 2019 Jun; 8():. PubMed ID: 31237563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucosylpolyphenols as Inhibitors of Aβ-Induced Fyn Kinase Activation and Tau Phosphorylation: Synthesis, Membrane Permeability, and Exploratory Target Assessment within the Scope of Type 2 Diabetes and Alzheimer's Disease.
    de Matos AM; Blázquez-Sánchez MT; Bento-Oliveira A; de Almeida RFM; Nunes R; Lopes PEM; Machuqueiro M; Cristóvão JS; Gomes CM; Souza CS; El Idrissi IG; Colabufo NA; Diniz A; Marcelo F; Oliveira MC; López Ó; Fernandez-Bolaños JG; Dätwyler P; Ernst B; Ning K; Garwood C; Chen B; Rauter AP
    J Med Chem; 2020 Oct; 63(20):11663-11690. PubMed ID: 32959649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse.
    Zhao H; Chang R; Che H; Wang J; Yang L; Fang W; Xia Y; Li N; Ma Q; Wang X
    Neurosci Lett; 2013 Sep; 551():12-6. PubMed ID: 23810804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knockout of p75 neurotrophin receptor attenuates the hyperphosphorylation of Tau in pR5 mouse model.
    Mañucat-Tan NB; Shen LL; Bobrovskaya L; Al-Hawwas M; Zhou FH; Wang YJ; Zhou XF
    Aging (Albany NY); 2019 Sep; 11(17):6762-6791. PubMed ID: 31479419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer's Disease Mice.
    Yao X; Xian X; Fang M; Fan S; Li W
    Front Aging Neurosci; 2019; 11():365. PubMed ID: 32082134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
    Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
    J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576.
    Chauhan NB; Siegel GJ; Feinstein DL
    Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
    Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
    J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.